6,11-bridged biaryl macrolides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8354383
APP PUB NO 20090264380A1
SERIAL NO

12399801

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses compounds of formula I, II or X, or pharmaceutically acceptable salts, esters, or prodrugs thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ENANTA PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kim, Heejin Belmont, US 247 2816
Kim, In Jong Lexington, US 54 1196
Liu, Tongzhu Auberdale, US 19 200
Long, Jiang Wayland, US 73 1456
Or, Yat Sun Watertown, US 408 12598
Phan, Ly Tam Quincy, US 74 864
Qiu, Yao-Ling Andover, US 106 3840
Wang, Guoqiang Belmont, US 210 5304
Wang, Yanchun Newton, US 53 444

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 15, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00